{"nct_id":"NCT01746108","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2013-06-18","start_date_type":"ACTUAL","primary_completion_date":"2015-06-29","primary_completion_date_type":"ACTUAL","completion_date":"2015-06-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}